Table of Contents PART 01: Executive summary  PART 02: Scope of  the report  PART 03: Research Methodology  PART 04: Introduction  Key market highlights  Prostate cancer: An overview  PART 05: Market landscape  Market overview  Market size and forecast  Five forces analysis  PART 06: Market segmentation  by product  Market overview  Global prostate needle biopsy market  Global prostate liquid biopsy market  PART 07: Market segmentation by end-user  Hospitals  ASCs  Diagnostic centers  Key buying criteria  PART 08: Geographical segmentation  Prostate biopsy market in Americas  Prostate biopsy market in EMEA  Prostate biopsy market in APAC  PART 09: Market drivers  Growing incidences of prostate cancer  Recurrent revenue from repeat biopsy tests  Growing number of diagnostic centers  PART 10: Impact of drivers  PART 11: Market challenges  Complications associated with prostate needle biopsies  High cost of biopsy procedure  Inaccurate test results  Limited technical skills  PART 12: Impact of drivers and challenges  PART 13: Market trends  New product launches and R&D activities  Growing demand for MRI and Ultrasound guided prostate biopsy procedures  High growth potential of prostate liquid biopsy tests  Growing focus toward combination of traditional and liquid biopsy tests  PART 14: Vendor landscape  Competitive scenario  PART 15: Key vendor analysis  C.R. Bard  Cook Medical  Endomed Systems  SOMATEX Medical Technologies  Biomedical  Other prominent vendors  PART 16: Appendix  List of abbreviations  PART 17: Explore Technavio  List of Exhibits Exhibit 01: Incidence rate of prostate cancer in different age groups 2015  Exhibit 02: Stages of prostate cancer and various diagnostics tools used for detection  Exhibit 03: Snapshot of global prostate biopsy market  Exhibit 04: Global prostate biopsy market 2016-2021 ($ millions)  Exhibit 05: Prostate cancer: Key statistics  Exhibit 06: Global prostate biopsy market analysis: Developed and emerging markets  Exhibit 07: Five forces analysis  Exhibit 08: Segmentation of global prostate biopsy market by product type  Exhibit 09: Two most common biopsies for prostate cancer  Exhibit 10: Share of each product type in the global prostate biopsy market 2016 and 2021 (%)  Exhibit 11: Global prostate biopsy market by product analysis 2016  Exhibit 12: Global prostate biopsy market: Lifecycle analysis 2016  Exhibit 13: Segmentation of global prostate biopsy market by product 2016-2021 ($ millions)  Exhibit 14: Segmentation of global prostate biopsy market by product 2016-2021 (%)  Exhibit 15: Global prostate needle biopsy market 2016-2021 ($ millions)  Exhibit 16: Types of prostate biopsy devices  Exhibit 17: Types of prostate biopsy guns  Exhibit 18: Percentage share of reusable and disposable prostate biopsy guns 2016  Exhibit 19: Benefits of advanced biopsy needles  Exhibit 20: Global prostate needle biopsy market segmentation percentage split 2016  Exhibit 21: Global prostate liquid biopsy market 2016-2021 ($ millions)  Exhibit 22: Global prostate biopsy market by end-user 2016 (%)  Exhibit 23: Factors affecting the purchase decision of prostate biopsy devices  Exhibit 24: Global prostate biopsy market segmentation by geography 2016-2021 (%)  Exhibit 25: Global prostate biopsy market analysis by geography 2016  Exhibit 26: Global prostate biopsy market: Geography market growth lifecycle analysis 2016  Exhibit 27: Country wise presence of global prostate biopsy market  Exhibit 28: Geographical overview of global prostate biopsy market 2016-2021  Exhibit 29: Prostate biopsy market in Americas 2016-2021 ($ millions)  Exhibit 30: Prostate biopsy market in EMEA 2016-2021 ($ millions)  Exhibit 31: Prostate biopsy market in APAC 2016-2021 ($ millions)  Exhibit 32: Global prostate biopsy market by geography 2016-2021 ($ millions)  Exhibit 33: Global prostate biopsy market by geography 2016-2021 (%)  Exhibit 34: Impact of drivers  Exhibit 35: Cost of biopsies for uninsured people in US, 2015  Exhibit 36: Impact of drivers and challenges  Exhibit 37: Competitive structure analysis of global prostate biopsy market 2016  Exhibit 38: Competitive parameters in global prostate biopsy market  Exhibit 39: C.R. Bard strength assessment  Exhibit 40: C.R. Bard strategy assessment  Exhibit 41: C.R. Bard opportunity assessment  Exhibit 42: Key highlights of Cook Medical  Exhibit 43: Cook Medical strength assessment  Exhibit 44: Cook Medical strategy assessment  Exhibit 45: Cook Medical opportunity assessment  Exhibit 46: Endomed Systems strength assessment  Exhibit 47: Endomed Systems strategy assessment  Exhibit 48: Endomed Systems opportunity assessment  Exhibit 49: Key highlights of SOMATEX Medical Technologies  Exhibit 50: SOMATEX Medical Technologies strength assessment  Exhibit 51: SOMATEX Medical Technologies strategy assessment  Exhibit 52: SOMATEX Medical Technologies opportunity assessment  Exhibit 53: Key highlights of Biomedical  Exhibit 54: Biomedical strength assessment  Exhibit 55: Biomedical strategy assessment  Exhibit 56: Biomedical opportunity assessment  

C.R. Bard, Cook Medical, Endomed Systems, SOMATEX Medical Technologies, Biomedical, Amecath, AprioMed, Argon Medical Devices, Biopsybell, Boston Scientific, Exosome Diagnostics, MDNA Life Sciences, MDxHealth, Möller Medical, Pathway Genomics, Predicine, Sterylab, TSK Laboratory Europe, UroMed, and Urotech.